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Background: Retroperitoneal lymphangiomatosis (RL) is a rare form of primary
lymphedema featuring aberrant retroperitoneal lymphatic proliferation. It causes
recurrent cellulitis, repeated interventions, and poor life quality. This study aimed to
investigate proper diagnositc criteria and surgical outcomes for RL with extremity
lymphedema.
Methods: Between 2012 and 2018, 44 primary lower‐extremity lymphedema cases
received lymphoscintigraphy, magnetic resonance imaging, and single‐photon
electron computed tomography to detect RL. RL patients underwent vascularized
lymph node transfers (VLNT) for extremity lymphedema and intra‐abdominal side‐to‐
end chylovenous bypasses (CVB) for chylous ascites. Complications, CVB patency,
and quality of life were evaluated postoperatively.
Results: Six RL patients (mean age of 30.3 years) had chylous ascites with five had
lower‐extremity lymphedema. All CVBs remained patent, though one required re‐
anastomosis, giving a 100% patency rate. Four unilateral and one bilateral extremity
lymphedema underwent six VLNTs with 100% flap survival. Patients reported
improved quality of life (P = 0.023), decreased cellulitis incidence (P = 0.041), and
improved mean lymphedema circumference (P = 0.043). All patients resumed a
normal diet and activity.
Conclusions: Evaluating primary lower‐extremity lymphedema patients with MRI and
SPECT could reveal a 13.6% prevalence of RL and guide treatment of refractory
extremity lymphedema. Intra‐abdominal CVB with VLNT effectively treated RL with
chylous ascites and extremity lymphedema.
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1 | INTRODUCTION
Lymphangiomatosis is a rare condition of unknown incidence with
diffuse involvement of all tissue types through hyperproliferation of
lymphatic vasculature, causing multiple lymphangiomas.1,2 This
condition affects more children than adults.2,3 Lymphangiomatosis
is classified as either generalized lymphangiomatosis or Gorham
Stout syndrome, with the former primarily involving soft tissue and
viscera and secondary osseous involvement, while the latter features
lymphovascular proliferation within bones and occasional soft tissue/
viscera involvement.3,4 Major complications of lymphangiomatosis
include chylothorax, chylous pericardial effusions, and chylous
ascites.5,6 Chylous ascites has a poor prognosis without hope of
spontaneous resolution. Persistent loss of chyle can also cause
nutritional imbalances.7,8 Retroperitoneal lymphangiomatosis (RL)
with concomitant lower‐limb lymphedema has also been reported.9
Current standards of care for these complications largely involve
symptomatic relief by thoracentesis, pleurodesis, or paracentesis and
combined therapy for any lymphedema.10
While medical and surgical management of RL exist, not all are
effective or even resolve secondary chylous ascites or lower‐
extremity lymphedema. There was limited evidence for proposed
medical treatments such as bisphosphonate, sirolimus, interferon,
and radiotherapy.2,7,8 There was also a paucity in interventional
methods as well, especially for chylous ascites.
Kinmonth first described a series of patients with lower‐extremity
lymphedema caused by ectatic lymphatic channels in the abdomen,
involving the retroperitoneum to the mesentery/intestines. Treatment
included repairing leaks, ligating incompetent channels, and resection
(eg, intestinal resection, hysterectomy).9 Sclerotherapy has also been
proposed with varied reception.8,10-12 Noel et al reported 4 chylovenous
anastomoses out of 26 surgical procedures in 30 patients with primary
chylous disorders.10 Campisi et al opted for exeresis, CO2 laser
treatments, and chylovenous/lymphovenous shunts in 12 patients with
primary chylous ascites (not all had RL).8 Their shunt techniques varied,
with direct lymphatic duct repair to the subcutaneous venous
anastomosis, chylous channel/cyst‐to‐venous shunt anastomosis, or
lymphatic‐to‐venous anastomosis using vein grafts. Yet, anastomoses
details were not reported, such as the level a technique was performed
at or specific technique outcomes.8,9
To address such issues, our study aimed to investigate standardized
diagnostic criteria and surgical outcomes of intra‐abdominal chylove-
nous bypass (CVB) with vascularized lymph node transfer (VLNT) for RL
with chylous ascites and concomitant lower‐extremity lymphedema.
2 | MATERIALS AND METHODS
Between 2012 and 2018, patients who presented with primary
lymphedema or chylous discharge were retrospectively reviewed
with institutional review board approval (IRB: 201801591B0) at
Linkou Chang Gung Memorial Hospital. Each patient diagnosed with
chylous ascites underwent an assessment to discover the etiology,
ranging from clinical measurements to imaging to detection of
albumin levels. Ultrasound Doppler and computed tomography
angiography (CTA) were utilized to rule out any proximal vascular
lesions and to evaluate the patency of any VLNT for lower‐extremity
lymphedema.13 Lymphoscintigraphy was performed, and Taiwan
Lymphoscintigraphy Staging was used to interpret findings of partial
or total lymphatic obstruction of the lower extremities.14 Magnetic
resonance imaging (MRI) was performed to confirm extravasation of
contrast into the peritoneal cavity and to visualize aberrant
lymphatic tracts in the soft tissue. Since 2018, single‐photon emission
computed tomography (SPECT) was added to support the presence
of abnormal retroperitoneal lymphatic tracts and evaluate disease
extent. Indocyanine green (ICG) lymphography was performed in
cases of mild extremity lymphedema.
When a patient was confirmed to have extremity lymphedema of
Cheng's Grade II‐IV, VLNT was suggested to first relieve the extremity
lymphedema, followed by CVB to address the chylous ascites. The
clinical rationale for performing VLNT instead of lymphovenous
anastomosis (LVA) for extremity lymphedema was that prior studies
had demonstrated that LVA is indicated for cases of Cheng
Lymphedema Grade I‐II lymphedema while VLNT is indicated for Grade
II‐IV lymphedema.14 Donor VLNT flaps were selected from the
omentum or submental basins.15 Patients were monitored immediately
after CVB in a microsurgical ICU ward for 3 to 5 days before being
transferred to a regular ward. Patients were followed postoperatively
and evaluated for changes in limb circumference, chylous ascites,
patency of the CVB by CTA, complications, body weight, and nutrition.
Patients were also asked to rate their quality of life (QoL) using a visual
analog score scaled 1 to 10 at their initial and latest clinical visit, with 1
being the poorest and 10 being the best.
2.1 | Technique for VLNT
The preoperative evaluation and technique of VLNT have previously
been described by the authors.16-18 Before the intra‐abdominal CVB,
the patency and effectiveness of any prior VLNT were tested by
Doppler ultrasound and CTA. If the VLNT demonstrated impaired
venous flow, it was revised, and the pedicle was confirmed to be
patent with the adequate flow at the time of intra‐abdominal CVB.
2.2 | Techniques for intraabdominal chylovenous
bypass
The abdomens of patients were opened with a 15 cm incision for
an exploratory laparotomy by a general surgeon (K‐H Liu).
Surgical exploration then identified the potential site of damaged
lymphatics responsible for chyle leakage in the RL soft tissue, as
evidenced by focal milky fluid exudate. The precise site of leakage
was confirmed under a microscope (Zeiss OPMI Pentero 800,
Jena, Germany) at 20‐25× magnification, with the location
typically being between the level of the umbilicus and the
anterior superior iliac spine around the ureter and internal iliac
artery. A 4 mm diameter hole was created by bipolar cautery in
lymphangiomatosis soft tissue as a controlled outlet for chyle.
The ovarian vein was then identified in relation to the outlet. If
the distance between the ovarian vein and outlet could not be
bridged without tension, branches from the internal iliac vein
were then identified as alternative recipient veins and dissected
free. The designated recipient vein was separated distally. The
distal end of the vein was then anastomosed to the artificial hole
in a side‐to‐end fashion with 8 to 12 stitches using 9‐0 nylon. ICG
(0.1 ml) was injected into the distal site of RL. Fluorescent flow
was seen under microscopy to travel from the lymphangiomatosis
through the anastomosis and to the recipient vein, verifying
intraoperative CVB patency.
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2.3 | Statistical analysis
Data before and after VLNT and CVB, including data on clinical
monitoring of chylous ascites, body weight, subjective QoL measures,
and circumferential sizes of limbs, were collected and analyzed with
IBM SPSS Statistics 20 statistical software (IBM Corporation,
Armonk, NY). Data were reported as the mean ± standard deviation,
and the circumference of the lower limbs measured 15 cm proximal
to the patella, 15 cm distal to the patella, and 10 cm proximal to the
ankle. Comparisons between groups were performed using the
Wilcoxon signed rank test. A two‐tailed P value < 0.05 was
considered statistically significant.
3 | RESULTS
A total of 44 primary lymphedema patients were evaluated at Linkou
Chang Gung Memorial Hospital between 2012 and 2018. Six of the
forty‐four patients were diagnosed with RL (incidence: 13.6%). There
were seven primary lymphedema patients who received abdominal
SPECT and MRI with results possibly indicative of RL, prompting
exploratory laparotomy. Exploration found RL in six of the seven
patients. The specificity of SPECT plus MRI was 85.7% (6/7) in
determining RL in primary lymphedema patients.
The average age of patients was 30.3 years (range 14‐55 years)
(Table 1). All were female. Four patients presented with unilateral
lower‐extremity lymphedema, with two patients presenting with
chyle leakage in the thigh, and one presenting with bilateral lower‐
extremity lymphedema (Figure 1, Table 1). The mean preoperative
Cheng Lymphedema Grade of the six lymphedematous limbs was 2.7
(range 1‐4). Of the six patients, four underwent five VLNTs before
CVB, one underwent CVB only, and one underwent VLNT simulta-
neously with the CVB (Figure 1). The average time between CVB and
VLNT was 23.6 ± 23.9 months (Table 1). Ultrasound Doppler studies
showed patency and good flow in all pedicle anastomoses in the six
VLNTs without stenosis, and CTA demonstrated uncompromised
VLNTs. All six patient MRIs revealed chylous ascites, and lymphos-
cintigraphy confirmed partial or total obstruction in the lower
extremity (Figure 2).
F IGURE 1 Case 1: Initial imaging and follow‐up imaging. A, Pelvic X‐ray revealed left femoral shaft and head fractures with an internal
prosthesis and wiring fixation of a left iliac osteolytic fracture. B, MRI showed extravasation of contrast media to the left pelvis, left femoral
area, and bilateral paraspinal regions, consistent with retroperitoneal lymphangiomatosis. The soft tissue of the left pelvis and thigh showed
characteristic honeycomb lymphedematous fibrosis. C,D, Computed tomography angiography revealed a patent chylovenous bypass (indicated
by the yellow arrow) at the left iliac region without chylous ascites at 3 weeks (C, coronal section) and 3 months (D, sagittal section)
postoperatively [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 2 Case 5: Lymphoscintigraphy, single‐photon emission computed tomography, and intraoperative images with indocyanine green
confirmation. A, Anterior and posterior planar imaging of the lower extremities at 5minutes and 2 hours post subcutaneous injection of 0.5/
0.5 mCi Tc‐99m phytate. Lymphoscintigraphy revealed reduced inguinal/pelvic lymph nodes uptake and dermal backflow over the entire left
lower limb with no major abnormalities in the right lower limb in comparison. B, Accumulated tracer along the left iliac vessels/paraaortic area
was suggestive of possible lymphangiomatosis with dilated lymphatic ducts in single‐photon emission computed tomography. C, Chyle
(aspirated by a syringe) was actively leaking from the soft tissue of the retroperitoneal lymphangiomatosis intraoperatively at the prespinal
area. D, Two chylovenous bypasses were performed with 9‐0 Nylon in a side‐to‐end fashion (yellow arrows indicating side‐to‐end anastomosis
sites). E, Intraoperative ICG imaging confirmed patency of the chylovenous bypasses. ICG, indocyanine green [Color figure can be viewed at
wileyonlinelibrary.com]
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The average albumin level changed from 3.1 ± 0.6 g/dL pre‐CVB
to 3.3 ± 0.7 g/dL post‐CVB (P = 0.500). The mean body weights
pre‐ and post‐CVB were 56.7 ± 14.1 kg and 53.5 ± 10.7 kg, respec-
tively (P = 0.07). Mean limb circumference after VLNT and CVB
significantly improved by 4.2 ± 2.2 cm (P = 0.043), and improved
2.6 ± 2.9 cm above the knee (P = 0.068), 5.9 ± 4.7 cm below the knee
(P = 0.042), and 3.3 ± 2.2 cm above the ankle (P = 0.078). Mean
cellulitis incidence significantly declined from 1.9 ± 1.8 to 0.1 ± 0.4
times/year postoperatively (P = 0.04) (Table 2).
Immediate patency of the CVB was verified in all patients
through intraoperative ICG microscopy (Figure 2). The average
cohort length of stay after CVB was 14.2 ± 4.1 days (Table 3).
Before discharge, all patients had <30 mL/day of chylous output
from abdominal drains. No abdominal drains needed to be
reinserted. One patient experienced post‐CVB complications of
perforation of the jejunum and thrombosis of the chylovenous
anastomosis site, which required resection with primary repair of
the jejunum and thrombectomy with re‐anastomosis of the CVB,
respectively. By discharge, all patients were able to return to
normal activity. Patients were able to tolerate a regular diet
instead of a low‐fat diet by 6 months postoperatively without
recurrence of chylous ascites (Table 3). The resolution of chylous
ascites in addition to patency of the CVB was verified through CTA
at postoperative visits for all patients. In addition, during follow‐up
surveillance, five of six patients were able to discontinue the use of
compression garments for lymphedematous extremities by 6
months, with one patient continuing to require compression
garments for 8 to 10 hours during the day for thigh lymphedema
(Figure 4) (Table 3). The mean QoL score significantly improved
from 3.4 ± 0.8 at before the operation to 5.7 ± 1.3 after the
operation (P = 0.023).
4 | DISCUSSION
Utilization of abdominal MRI was initiated due to the VLNT‐
refractory nature of extremity lymphedema with additional abdom-
inal symptoms. MRI demarcated soft tissue changes and lymphatic
proliferation of lymphangiomatosis. SPECT in the last four patients
helped further elucidate the disease extent. Overall, lymphoscinti-
graphy, MRI, and SPECT were able to definitively demonstrate
chylous ascites secondary to RL (Figure 3).
Once VLNT was demonstrated to be inadequate for the
concomitant lower‐extremity lymphedema, CVB was performed as
a potential physiologic treatment for the extravasating lymph causing
the lymphedema and chylous ascites. The CVB procedure appeared
to be effective in treating the chylous ascites, as supported by the
absence of clinically detectable ascites with imaging validation in all
six patients. In addition, after CVB, there was an additional significant
reduction in leg circumference below the knee beyond the VLNT‐
related reduction (P = 0.042). The only exception to this trend was
patient 5, who removed her compression garments only during her
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The single patient in our study unable to discontinue wearing
compression garments postoperatively opted to do so for comfort, as
her occupation requires her to stand for prolonged periods of time.
A potential mechanism for our observations is that the CVB
technique creates a controlled outlet for high‐volume chyle leakage
from the lymphangiomatosis. This opening enables the drainage of
chyle/lymph from the retroperitoneal space directly back to the
venous system without passing into the thoracic ducts. Joining the
lymphatic system with the systemic venous system thereby functions
as a near‐physiologic solution that not only prevents ascites but also
limits protein loss and excessive lymphatic drainage to the
extremities, which could otherwise contribute to hypoalbuminemia,
lymphedema, infection, and soft tissue or bone damage.
Interestingly, although CVB theoretically enables the return of
lost products to the systemic circulation, not all patients presented
with hypoalbuminemia pre‐CVB, and not all patient presented an
improvement in albumin level post‐CVB (P = 0.500). The lack of
consistent hypoalbuminemia in the series could be a reflection of the
duration of chylous ascites, with perhaps normal albumin levels
reflecting earlier stages of RL. Persistently low albumin levels at
follow‐up may be due to slow replenishment after a prolonged loss in
the form of chylous ascites.
Patient body weights may decrease after VLNT but increase after
CVB. It is difficult to determine the cause of a significant difference
when the patients have undergone two procedures. However, the fact
that all but one patient could tolerate a normal diet without weight gain
should be considered. The 4.6 kg gain in patient 1 is likely actually a
reflection of clinical improvement, as she was underweight at 33.4 kg as
a fully grown adult as a result of her severe, chronic malnourishment
from chylous leakage alongside her numerous other disease states.
Although the time between when VLNT and CVB were
performed varied, the rate of resolution of the chylous ascites or
lower‐extremity lymphedema improvement remained unchanged.
These results do not indicate that VLNT was unhelpful; however,
patients still had decreased chyle output and decreased lower
extremity circumference with VLNT alone. Further studies with
multivariate component analysis would be better suited to parse the
contributions of VLNT vs CVB.
One concern that was later considered by the authors during the
course of the series was that the omental lymph node transfer may not
F IGURE 3 Proposed algorithm for the diagnosis and treatment of retroperitoneal lymphangiomatosis stepwise diagnostic pathway for
work‐up, differential diagnoses of possible causes of lower extremity lymphedema
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necessarily be effective for the extremity lymphedema, as the omental
lymph nodes mainly drain the abdominal chyle. If the lower‐extremity
lymphedema observed was truly due to chylous ascites causing
lymphatic leakage into the legs, then the omental VLNT would be
ineffective, as drainage of chyle in situ proved inadequate. In patients 4
and 5, the lower extremities underwent lymph node transfer without
removing nodes from the abdomen. Patient 2 did not have lower‐
extremity lymphedema and thus did not undergo VLNT, although it is
possible she could have eventually developed lymphedema had her
disease not been caught early. The measurements of patient 1 could
not be standardized given her left hip disarticulation.
There are many challenges in performing a CVB: coordination with a
general surgeon for exploration and reconstructive microsurgeon for
anastomosis; a deep, chyle‐flooded operative field; intestinal peristalsis
causing movement; limited recipient vessels; requirement for longer
microsurgical instruments; and having to perform anastomosis of a vein
to a literal hole in the wall of the retroperitoneum under a microscope.
The anastomosis itself is technically challenging, requiring multiple
interrupted sutures while avoiding leakages and controlling internal
bleeding. Continuous suturing is inadvisable, as this technique can
narrow the anastomosis, resulting in low flow or thrombosis that could
lead to inadequate chyle drainage.
Maegawa et al described using vein grafts to resolve cutaneous chyle
leakages in the lower limb from the dilated lymphatic duct to the adjacent
saphenous vein at two levels.19 In comparison, we identified the
intraabdominal abnormalities as the source of chylous ascites and chose
to perform CVB from the incompetent tissue deep in the abdominal
cavity to a low resistance path into the local venous system. By doing so,
we bypassed the chyle leak and prevented continued lymphatic output
from the lymphangiomas, resulting in complete treatment.
This study also provides a descriptive framework of how one might
diagnose RL, particularly if there is no overt primary complaint of
chylous ascites (Figure 3). Further studies of the outcomes of CVB on
RL with chylous ascites and lower‐extremity lymphedema are needed to
validate the operative safety, outcomes, and long‐term resolution.
5 | CONCLUSIONS
RL with chyle leakage and lower‐limb lymphedema is a disease that is
difficult to diagnose and treat. Lymphoscintigraphy, SPECT, and MRI are
the recommended imaging modalities for diagnosing RL in primary
lymphedema patients and/or patients with chylous ascites. Although the
data are limited, CVB with vascularized lymph node flap transfer is
recommended as a first‐line measure for effective shunting of chyle into
the intraabdominal venous system, simultaneously resolving the second-
ary lower‐extremity lymphedema.
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F IGURE 4 Preoperative and postoperative photographs of the retroperitoneal lymphangiomatosis with left lower extremity lymphedema of
patient 5. A, Preoperative evaluation of patient 5′s left lower extremity immediately after removal of her compression garments, demonstrating
characteristic fibro‐adipose tissue deposits and lymphedematous enlargement throughout from left thigh to left foot. B, Postoperative day 15
imaging of the patient following her vascularized lymph node transfer and chylovenous bypass, showing reduction in circumference around the
region above her knee, below her knee, and over the dorsal aspect of her foot, with protuberance around the ankle largely due to the VLNT. C,
Follow‐up imaging of the patient's left leg at 11 months with measurements above the knee, below the knee, and above the ankle still slightly
improved compared with preoperative measurements despite not wearing compression garments since surgery and standing for long stretches
constantly at her occupation. VLNT, vascularized lymph node transfer [Color figure can be viewed at wileyonlinelibrary.com]
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